Scientific publications

Laboratory Investigation, 2026
Tumor-infiltrating Basophils Are Associated With Improved Prognosis in Colorectal Cancer

Rahkola O., Karjalainen H., Äijälä V. et al.

Antioxidants, 2026
N-Acetylcysteine Attenuates Oxidative Stress and Preserves Red Blood Cell Quality During Whole Blood Storage

Eligini S., Brocca L., Mallia A. et al.

Journal of Inflammation Research, 2026
Artemin Serves as a Novel Predictive Biomarker and Exerts a Protective Effect Against Preterm Birth

Zhang J., Mei S., Li Y. et al.

Frontiers in Immunology, 2026
Serum immune profiling suggests overlap between IBD patients with joint complaints and patients with spondyloarthritis

Veltkamp S., van Gaalen F., de Bruin L. et al.

The Journal of Pharmacology and Experimental Therapeutics, 2026
Blocking IL-33 reduces joint, systemic, and lung inflammatory responses in the combined collagen-induced arthritis-inhalant endotoxin exposure model

Poole J., Larsen J., Thiele G. et al.

Journal for ImmunoTherapy of Cancer, 2026
Plasma proteomics predicts pathological complete response and reveals LIF as a potential mediator of resistance to neoadjuvant immunochemotherapy in resectable NSCLC

Feng S., Feng Z., Xie S. et al.

Frontiers in Cell and Developmental Biology, 2026
A discovery protein panel for brain predicted age discordance using MRI in neurologically healthy individuals

Gill J., Lim A., Esopenko C. et al.

Journal of Asthma, 2026
Proton pump inhibitor target genes and asthma susceptibility: a Mendelian randomization study with identification of IL-2 as a potential mediator

Gu L., Li J., Yin Z. et al.

Nature Communications, 2026
Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy

Moustardas P., Setterud H., Meijer H. et al.

Neuropsychopharmacology, 2026
CSF galanin and noradrenaline downregulation by psilocybin therapy in major depressive disorder

Paslawski W., Doyon D., Ekman C. et al.

HemaSphere, 2026
Inflammatory signatures in the spectrum of myeloid diseases

Ibbotson A., Crouch S., Ferrari J. et al.

Molecular Biomedicine, 2026
Plasma proteomics-based liquid biopsy for predicting efficacy of PD-1-based immunochemotherapy in advanced gastric cancer: a prospective cohort study

Meng E., Cheng X., Wu X. et al.

Journal of Advanced Research, 2026
Mapping sarcopenia’s causal proteome reveals a leptin-driven inflammatory-mitochondrial axis for early prediction

Sun J., Yan M., Jiang D. et al.

Scientific Reports, 2026
A case–control study of mid-pregnancy circulating cardiovascular proteins in women with subsequent preeclampsia and small for gestational age births

Callbo P., Junus K., Lindberger E. et al.

Journal of Clinical Immunology, 2026
Adult-Onset LRBA Deficiency Presenting with Rheumatoid Arthritis–Like Manifestations: A Case Report

Ninagawa K., Kudo Y., Kono M. et al.

Ophthalmology Science, 2026
Associations of Host Genetics and Plasma Proteomics with Incident Age-related Macular Degeneration in Persons with AIDS

Hunt P., Sezgin E., Olshen A. et al.

Journal of Molecular Medicine, 2026
Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome

Ulutekin C., Can A., Súkeníková L. et al.

Journal of Proteome Research, 2026
Identification of Age-Associated Circulating Proteins and Lipids in 3800 Comorbidity-Enriched Older Adults from Japan-Based Cohorts Using Olink Assays and MRM Mass Spectrometry

Tokuoka S., Hamano F., Kobayashi A. et al.

Journal of Advanced Research, 2026
Processed meat intake and incident gout: Integrated evidence from epidemiology, plasma proteomics, and machine learning

Wang Z., Shi D., Pan X. et al.

Journal of the American Heart Association, 2026
Proteomics‐Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank

Sakr S., Medina‐Inojosa J., Liu C. et al.